Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 143

1.

Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.

Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Takahashi M, Nakagawara J, Iida H, Kishimoto T, Nagatsuka K.

Neuroimage Clin. 2016 Dec 2;13:209-214. doi: 10.1016/j.nicl.2016.11.029.

2.

Interhemispheric functional disconnection because of abnormal corpus callosum integrity in bipolar disorder type II.

Yasuno F, Kudo T, Matsuoka K, Yamamoto A, Takahashi M, Nakagawara J, Nagatsuka K, Iida H, Kishimoto T.

BJPsych Open. 2016 Nov 1;2(6):335-340.

3.

Incidence, predictors, and etiology of subsequent ischemic stroke within one year after transient ischemic attack.

Uehara T, Minematsu K, Ohara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Takagi S, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Uchiyama S, Matsumoto M, Iihara K, Toyoda K; PROMISE-TIA study Investigators..

Int J Stroke. 2017 Jan;12(1):84-89. doi: 10.1177/1747493016669884.

PMID:
27649736
4.

Reconsideration of Hemodynamic Cerebral Ischemia Using Recent PET/SPECT Studies.

Nakagawara J.

Acta Neurochir Suppl. 2016;123:99-108. doi: 10.1007/978-3-319-29887-0_14.

PMID:
27637635
5.

Differences in Clinical Characteristics between Patients with Transient Ischemic Attack Whose Symptoms Do and Do Not Persist on Arrival.

Tanaka K, Uehara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Takagi S, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Nagao T, Uchiyama S, Matsumoto M, Iihara K, Toyoda K, Minematsu K; Japan TIA Research Group, 2009-2011..

J Stroke Cerebrovasc Dis. 2016 Sep;25(9):2237-42. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.025.

PMID:
27266623
6.

Analysis of Factors Associated with Progression and Long-Term Outcomes of Penetrating Artery Territory Infarction: A Retrospective Study.

Takeuchi M, Miyashita K, Nakagawara J, Toyoda K, Todo K, Metoki N, Suzuki R, Manabe Y, Akaiwa Y, Yamamoto Y, Nagatsuka K.

J Stroke Cerebrovasc Dis. 2016 Aug;25(8):1952-9. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.007.

PMID:
27199201
7.

Cardiovascular events occur independently of high on-aspirin platelet reactivity and residual COX-1 activity in stable cardiovascular patients.

Nagatsuka K, Miyata S, Kada A, Kawamura A, Nakagawara J, Furui E, Takiuchi S, Taomoto K, Kario K, Uchiyama S, Saito K, Nagao T, Kitagawa K, Hosomi N, Tanaka K, Kaikita K, Katayama Y, Abumiya T, Nakane H, Wada H, Hattori A, Kimura K, Isshiki T, Nishikawa M, Yamawaki T, Yonemoto N, Okada H, Ogawa H, Minematsu K, Miyata T.

Thromb Haemost. 2016 Aug 1;116(2):356-68. doi: 10.1160/TH15-11-0864.

PMID:
27098431
8.

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke.

Amarenco P, Lavallée PC, Labreuche J, Albers GW, Bornstein NM, Canhão P, Caplan LR, Donnan GA, Ferro JM, Hennerici MG, Molina C, Rothwell PM, Sissani L, Školoudík D, Steg PG, Touboul PJ, Uchiyama S, Vicaut É, Wong LK; TIAregistry.org Investigators..

N Engl J Med. 2016 Apr 21;374(16):1533-42. doi: 10.1056/NEJMoa1412981.

9.

Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study).

Onozuka D, Hagihara A, Nishimura K, Kada A, Nakagawara J, Ogasawara K, Ono J, Shiokawa Y, Aruga T, Miyachi S, Nagata I, Toyoda K, Matsuda S, Suzuki A, Kataoka H, Nakamura F, Kamitani S, Nishimura A, Kurogi R, Sayama T, Iihara K; J-ASPECT Study Collaborators..

BMJ Open. 2016 Mar 15;6(3):e009942. doi: 10.1136/bmjopen-2015-009942.

10.

A multicenter, prospective, observational study of warfarin-associated intracerebral hemorrhage: The SAMURAI-WAICH study.

Osaki M, Koga M, Maeda K, Hasegawa Y, Nakagawara J, Furui E, Todo K, Kimura K, Shiokawa Y, Okada Y, Okuda S, Kario K, Yamagami H, Minematsu K, Kitazono T, Toyoda K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement Study Investigators..

J Neurol Sci. 2015 Dec 15;359(1-2):72-7. doi: 10.1016/j.jns.2015.10.031.

PMID:
26671089
11.

Effects of Surgery and Antiplatelet Therapy in Ten-Year Follow-Up from the Registry Study of Research Committee on Moyamoya Disease in Japan.

Yamada S, Oki K, Itoh Y, Kuroda S, Houkin K, Tominaga T, Miyamoto S, Hashimoto N, Suzuki N; Research Committee on Spontaneous Occlusion of Circle of Willis (Moyamoya Disease)..

J Stroke Cerebrovasc Dis. 2016 Feb;25(2):340-9. doi: 10.1016/j.jstrokecerebrovasdis.2015.10.003.

PMID:
26654669
12.

[Regional Management of Stroke Care and Neurosurgery].

Nakagawara J.

No Shinkei Geka. 2015 Dec;43(12):1055-70. doi: 10.11477/mf.1436203182. Review. Japanese. No abstract available.

PMID:
26646172
13.

Significance of the Hemorrhagic Site for Recurrent Bleeding: Prespecified Analysis in the Japan Adult Moyamoya Trial.

Takahashi JC, Funaki T, Houkin K, Inoue T, Ogasawara K, Nakagawara J, Kuroda S, Yamada K, Miyamoto S; JAM Trial Investigators..

Stroke. 2016 Jan;47(1):37-43. doi: 10.1161/STROKEAHA.115.010819.

14.

The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study.

Hosomi N, Nagai Y, Kohriyama T, Ohtsuki T, Aoki S, Nezu T, Maruyama H, Sunami N, Yokota C, Kitagawa K, Terayama Y, Takagi M, Ibayashi S, Nakamura M, Origasa H, Fukushima M, Mori E, Minematsu K, Uchiyama S, Shinohara Y, Yamaguchi T, Matsumoto M; J-STARS Collaborators..

EBioMedicine. 2015 Aug 6;2(9):1071-8. doi: 10.1016/j.ebiom.2015.08.006.

15.

Clinical Characteristics of Transient Ischemic Attack Patients with Atrial Fibrillation: Analyses of a Multicenter Retrospective Study.

Hama Y, Uehara T, Ohara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Takagi S, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Nagao T, Uchiyama S, Matsumoto M, Iihara K, Toyoda K, Minematsu K.

Cerebrovasc Dis Extra. 2015 Jul 9;5(2):84-90. doi: 10.1159/000434689.

16.

Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke.

Mori E, Minematsu K, Nakagawara J, Hasegawa Y, Nagahiro S, Okada Y, Truelsen T, Lindsten A, Ogawa A, Yamaguchi T; DIAS-J Investigators..

Stroke. 2015 Sep;46(9):2549-54. doi: 10.1161/STROKEAHA.115.009917.

17.

Results of Prospective Cohort Study on Symptomatic Cerebrovascular Occlusive Disease Showing Mild Hemodynamic Compromise [Japanese Extracranial-Intracranial Bypass Trial (JET)-2 Study].

Kataoka H, Miyamoto S, Ogasawara K, Iihara K, Takahashi JC, Nakagawara J, Inoue T, Mori E, Ogawa A; JET-2 Investigators..

Neurol Med Chir (Tokyo). 2015;55(6):460-8. doi: 10.2176/nmc.oa.2014-0424.

18.

Impact of injected dose and acquisition time on a normal database by use of 3D-SSP in SPECT images: quantitative simulation studies.

Onishi H, Hatazawa J, Nakagawara J, Ito K, Ha-Kawa SK, Masuda Y, Sugibayashi K, Takahashi M, Kikuchi K, Katsuta N.

Radiol Phys Technol. 2015 Jul;8(2):224-31. doi: 10.1007/s12194-015-0311-8.

PMID:
25758210
19.

Cognitive Dysfunction Survey of the Japanese Patients with Moyamoya Disease (COSMO-JAPAN Study): study protocol.

Takagi Y, Miyamoto S; COSMO-Japan Study Group..

Neurol Med Chir (Tokyo). 2015;55(3):199-203. doi: 10.2176/nmc.ra.2014-0326. Review.

20.

Blood glucose levels during the initial 72 h and 3-month functional outcomes in acute intracerebral hemorrhage: the SAMURAI-ICH study.

Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Hasegawa Y, Kario K, Arihiro S, Sato S, Homma K, Matsuki T, Kinoshita N, Nagatsuka K, Minematsu K, Toyoda K; SAMURAI Study Investigators..

J Neurol Sci. 2015 Mar 15;350(1-2):75-8. doi: 10.1016/j.jns.2015.02.018.

PMID:
25711829
Items per page

Supplemental Content

Loading ...
Support Center